Sam-A Pharm. Co., Ltd (KOSDAQ:009300)
South Korea · Delayed Price · Currency is KRW 16,140
+10 (0.06%)
At close: Feb 13, 2026
Sam-A Pharm. Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Net Income | 13,187 | 22,080 | 21,374 | 11,912 | 3,392 | 123.85 |
Depreciation & Amortization | 4,712 | 4,266 | 3,895 | 3,187 | 3,699 | 3,891 |
Loss (Gain) From Sale of Assets | -43.17 | - | - | - | - | - |
Loss (Gain) From Sale of Investments | -749.3 | -404.35 | -907.91 | 1,335 | 308.52 | 216.52 |
Loss (Gain) on Equity Investments | 1,305 | 932.85 | 915.83 | 1,290 | 2,464 | 4,195 |
Provision & Write-off of Bad Debts | -133.57 | 26.23 | -40.36 | - | 16.74 | -52.8 |
Other Operating Activities | -3,168 | 7.04 | -1,149 | 2,284 | 1,485 | -1,194 |
Change in Accounts Receivable | 4,959 | 3,510 | -1,090 | -3,427 | -2,638 | 6,598 |
Change in Inventory | -4,677 | -1,447 | -885.95 | -2,975 | 2,666 | -1,006 |
Change in Accounts Payable | -1,230 | 827.33 | -2,038 | 3,268 | 1,210 | -1,331 |
Change in Other Net Operating Assets | -2,540 | -4,551 | 686.51 | 2,730 | 339.61 | -2,032 |
Operating Cash Flow | 11,620 | 25,247 | 20,760 | 19,604 | 12,943 | 9,408 |
Operating Cash Flow Growth | -64.27% | 21.62% | 5.90% | 51.47% | 37.57% | -28.84% |
Capital Expenditures | -2,374 | -6,512 | -3,820 | -239.25 | -275.44 | -679.52 |
Sale of Property, Plant & Equipment | 29.4 | - | - | 140.21 | 4.55 | 54.1 |
Sale (Purchase) of Intangibles | -303.79 | 109.09 | 263.64 | 1,100 | 1,050 | 327.27 |
Investment in Securities | -19,960 | -15,160 | -17,251 | -24,423 | -34,375 | -2,180 |
Other Investing Activities | 385.02 | 151.75 | -0 | 10,390 | 13,800 | 2,280 |
Investing Cash Flow | -22,224 | -21,411 | -20,807 | -13,032 | -19,796 | -197.94 |
Long-Term Debt Issued | - | 5,000 | 5,000 | - | - | - |
Total Debt Issued | 3,000 | 5,000 | 5,000 | - | - | - |
Long-Term Debt Repaid | - | -3,945 | -2,670 | -3,855 | -1,839 | -1,834 |
Net Debt Issued (Repaid) | -2,729 | 1,055 | 2,330 | -3,855 | -1,839 | -1,834 |
Dividends Paid | -4,883 | -4,578 | -2,441 | -1,526 | -1,831 | -1,831 |
Financing Cash Flow | 1,441 | -3,522 | -111.77 | -5,381 | -3,670 | -3,665 |
Foreign Exchange Rate Adjustments | 207.76 | 217.64 | 2.45 | - | 111.9 | -147.12 |
Miscellaneous Cash Flow Adjustments | -0 | - | -0 | -0 | 0 | - |
Net Cash Flow | -8,955 | 531.73 | -156.46 | 1,191 | -10,411 | 5,397 |
Free Cash Flow | 9,246 | 18,735 | 16,940 | 19,365 | 12,667 | 8,728 |
Free Cash Flow Growth | -64.05% | 10.60% | -12.52% | 52.88% | 45.13% | -31.43% |
Free Cash Flow Margin | 12.06% | 19.60% | 17.43% | 23.70% | 23.17% | 16.27% |
Free Cash Flow Per Share | 1514.89 | 3069.67 | 2775.59 | 3172.89 | 2075.46 | 1430.09 |
Cash Interest Paid | 461.67 | 519.8 | 214.56 | 2.85 | 29.07 | 40.64 |
Cash Income Tax Paid | 6,825 | 7,481 | 7,186 | 4,228 | 802.31 | 3,076 |
Levered Free Cash Flow | 2,443 | 11,778 | 9,634 | 17,658 | 11,749 | 6,619 |
Unlevered Free Cash Flow | 2,779 | 12,115 | 9,771 | 17,697 | 11,827 | 6,746 |
Change in Working Capital | -3,489 | -1,660 | -3,327 | -403.53 | 1,577 | 2,228 |
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.